Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 4 » default
Lung Cancer: Targets and Therapy
- View all (129)
- Volume 11, 2020 (2)
- Volume 10, 2019 (16)
- Volume 9, 2018 (14)
- Volume 8, 2017 (25)
- Volume 7, 2016 (17)
- Volume 6, 2015 (9)
- Volume 5, 2014 (10)
- Volume 4, 2013 (9)
- Volume 3, 2012 (9)
- Volume 2, 2011 (6)
- Volume 1, 2010 (12)
Archive: Volume 4, 2013
Potential toxicity and safety evaluation of nanomaterials for the respiratory system and lung cancer
Vlachogianni T, Fiotakis K, Loridas S, Perdicaris S, Valavanidis A
Lung Cancer: Targets and Therapy 2013, 4:71-82
Published Date: 27 November 2013
Emerging treatments in lung cancer – targeting the RLIP76 molecular transporter
Goldfinger LE, Lee S
Lung Cancer: Targets and Therapy 2013, 4:61-69
Published Date: 5 November 2013
Practical management of NSCLC patients with long-term bevacizumab treatment: a report of four cases
Herder GJM, Codrington H, Colder CD, Aerts JG
Lung Cancer: Targets and Therapy 2013, 4:55-59
Published Date: 11 October 2013
Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond
Suda K, Mitsudomi T
Lung Cancer: Targets and Therapy 2013, 4:43-53
Published Date: 15 August 2013
Robotic stereotactic body radiation therapy for elderly medically inoperable early-stage non-small cell lung cancer
Karam SD, Horne ZD, Hong RL, Baig N, Gagnon GJ, McRae D, Duhamel D, Nasr NM
Lung Cancer: Targets and Therapy 2013, 4:35-42
Published Date: 7 August 2013
EGFR mutations in patients with lung adenocarcinoma in southwest China: are G719S/A and L861Q more likely detected in tumors derived from smokers?
Wang QS, Mou JH, Yang X, He Y, Li ZP, Luo QY, Li YQ, Lin L, Ma Y, Xiao HL
Lung Cancer: Targets and Therapy 2013, 4:27-33
Published Date: 1 July 2013
MET overexpression and gene amplification in NSCLC: a clinical perspective
Landi L, Minuti G, D'Incecco A, Salvini J, Cappuzzo F
Lung Cancer: Targets and Therapy 2013, 4:15-25
Published Date: 19 June 2013
Gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy
Sugiura Y, Nemoto E, Kawai O, Ohkubo Y, Fusegawa H, Kaseda S
Lung Cancer: Targets and Therapy 2013, 4:9-14
Published Date: 10 June 2013
Targeted inhibition in tumors with ALK dependency
Kwak EL, Clark JW, Shaw AT
Lung Cancer: Targets and Therapy 2013, 4:1-8
Published Date: 10 January 2013